Cargando…

Ligustrazine alleviates pulmonary arterial hypertension in rats by promoting the formation of myocardin transcription complex in the nucleus of pulmonary artery smooth muscle cells

Pulmonary arterial hypertension (PAH) is a pathophysiological state of abnormally elevated pulmonary arterial pressure caused by drugs, inflammation, toxins, viruses, hypoxia, and other risk factors. We studied the therapeutic effect and target of tetramethylpyrazine (tetramethylpyrazine [TMP]; ligu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Xichao, Wu, Mingjie, Meng, Qinhai, Zhu, Weijie, Zhang, Chenyan, Liu, Bowen, Qi, Yuewen, Gu, Shuqun, Wang, Xinyu, Wen, Jingli, Li, Yu, Qi, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432881/ https://www.ncbi.nlm.nih.gov/pubmed/37186419 http://dx.doi.org/10.1111/cts.13534

Ejemplares similares

Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis
por: Zhang, Chenyan, et al.
Publicado: (2022)

Similar regulatory mechanisms of caveolins and cavins by myocardin family coactivators in arterial and bladder smooth muscle
por: Zhu, Baoyi, et al.
Publicado: (2017)

YY1 directly interacts with myocardin to repress the triad myocardin/SRF/CArG box-mediated smooth muscle gene transcription during smooth muscle phenotypic modulation
por: Zheng, Jian-Pu, et al.
Publicado: (2020)

Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt‐related pulmonary arterial hypertension
por: Zhou, Jing‐jing, et al.
Publicado: (2022)

Arp5 is a key regulator of myocardin in smooth muscle cells
por: Morita, Tsuyoshi, et al.
Publicado: (2014)

The Role and Regulation of Pulmonary Artery Smooth Muscle Cells in Pulmonary Hypertension
por: He, Shixin, et al.
Publicado: (2020)

Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells
por: Liu, Ping, et al.
Publicado: (2021)

Ligustrazine Injection for Chronic Pulmonary Heart Disease: A Systematic Review and Meta-Analysis
por: Jian-sheng, Li, et al.
Publicado: (2012)

Intracellular iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension in mice
por: Lakhal-Littleton, Samira, et al.
Publicado: (2019)

Meta-Analysis of Clinical Efficacy and Safety of Ligustrazine in the Treatment of Idiopathic Pulmonary Fibrosis
por: Wu, Xiaozheng, et al.
Publicado: (2020)

Altered expression of nuclear and cytoplasmic histone H1 in pulmonary artery and pulmonary artery smooth muscle cells in patients with IPAH
por: Talati, Megha, et al.
Publicado: (2012)

Pharmacological Alteration of Cellular Mechanical Properties in Pulmonary Arterial Smooth Muscle Cells of Idiopathic Pulmonary Arterial Hypertension
por: Katsuragi, Shinichi, et al.
Publicado: (2021)

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension
por: Chen, Yong-Jie, et al.
Publicado: (2021)

Synemin promotes pulmonary artery smooth muscle cell phenotypic switch in shunt‐induced pulmonary arterial hypertension
por: Zhou, Jingjing
Publicado: (2022)

Endogenous Estrogen Attenuates Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Vasoconstriction and Pulmonary Arterial Smooth Muscle Cells Proliferation
por: Xu, Dunquan, et al.
Publicado: (2013)

Persistent Hypoxia with Intermittent Aggravation Causes Imbalance in Smad3/Myocardin-Related Transcription Factor Signaling with Consequent Endothelial Senescence and Pulmonary Arterial Remodeling
por: Hu, Jiaxin, et al.
Publicado: (2023)

Myocardin in biology and disease
por: Miano, Joseph M
Publicado: (2015)

Hyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK
por: Wilson, Jamie L., et al.
Publicado: (2015)

In Search of Novel Targets for Heart Disease: Myocardin and Myocardin-Related Transcriptional Cofactors
por: Mikhailov, Alexander T., et al.
Publicado: (2012)

Regulation of Pulmonary Vascular Smooth Muscle Contractility in Pulmonary Arterial Hypertension: Implications for Therapy
por: Lyle, Melissa A., et al.
Publicado: (2017)

Effect of EZH2 on pulmonary artery smooth muscle cell migration in pulmonary hypertension
por: Wang, Ying, et al.
Publicado: (2021)

Participation of PLK1 and FOXM1 in the hyperplastic proliferation of pulmonary artery smooth muscle cells in pulmonary arterial hypertension
por: Wilson, Jamie L., et al.
Publicado: (2019)

Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells
por: Price, Laura C., et al.
Publicado: (2015)

Effects of dexmedetomidine on porcine pulmonary artery vascular smooth muscle
por: Chikuda, Mami, et al.
Publicado: (2019)

Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension
por: Courboulin, Audrey, et al.
Publicado: (2011)

Unraveling endothelin-1 induced hypercontractility of human pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension
por: Wilson, Jamie L., et al.
Publicado: (2018)

Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells
por: Gao, Lan, et al.
Publicado: (2017)

Effects of cyclic stretch on the molecular regulation of myocardin in rat aortic vascular smooth muscle cells
por: Chiu, Chiung-Zuan, et al.
Publicado: (2013)

Dual Regulation of Myocardin Expression by Tumor Necrosis Factor-α in Vascular Smooth Muscle Cells
por: Singh, Pavneet, et al.
Publicado: (2014)

Nexilin/NEXN controls actin polymerization in smooth muscle and is regulated by myocardin family coactivators and YAP
por: Zhu, Baoyi, et al.
Publicado: (2018)

Myocardin regulates exon usage in smooth muscle cells through induction of splicing regulatory factors
por: Liu, Li, et al.
Publicado: (2022)

Role of smooth muscle cell p53 in pulmonary arterial hypertension
por: Wakasugi, Takayuki, et al.
Publicado: (2019)

SMYD2 Regulates Vascular Smooth Muscle Cell Phenotypic Switching and Intimal Hyperplasia via Interaction with Myocardin
por: Zhou, Yu, et al.
Publicado: (2023)

Zinc-mediated activation of CREB pathway in proliferation of pulmonary artery smooth muscle cells in pulmonary hypertension
por: Xiao, Genfa, et al.
Publicado: (2021)

NCAPG Promotes Pulmonary Artery Smooth Muscle Cell Proliferation as a Promising Therapeutic Target of Idiopathic Pulmonary Hypertension: Bioinformatics Analysis and Experiment Verification
por: Fu, Bowen, et al.
Publicado: (2022)

Inhibition of SRF/myocardin reduces aortic stiffness by targeting vascular smooth muscle cell stiffening in hypertension
por: Zhou, Ning, et al.
Publicado: (2017)

Blockade of JAK2 protects mice against hypoxia‐induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation
por: Zhang, Lei, et al.
Publicado: (2020)

Evidence for Hypoxia-Induced Shift in ATP Production from Glycolysis to Mitochondrial Respiration in Pulmonary Artery Smooth Muscle Cells in Pulmonary Arterial Hypertension
por: Akagi, Satoshi, et al.
Publicado: (2023)

Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells
por: Ali, Omar F, et al.
Publicado: (2011)

Mir-206 Regulates Pulmonary Artery Smooth Muscle Cell Proliferation and Differentiation
por: Jalali, Samuel, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4pkjffv6s7mf5fqttenrum5bos